GSK wins essenscia Innovation Award for shingles vaccine

October 18, 2016 News BioVox

GSK Vaccines, a world leader in vaccines based in Wavre, wins the biennial essenscia Innovation Award thanks to its candidate vaccine against shingles. The Innovation Award is the award for the most promising innovation in the Belgian chemical and life sciences sector. “It’s never easy to compare projects from such different domains, but the jury was unanimous on the choice of the winner,” says François Cornélis, jury chairman and former head of PetroFina and ToTal. “This is top Belgian research, which will create  added value and more employment.”

Avatar photo

With a local focus and global reach, the news platform BioVox shares insights into the Benelux life sciences ecosystem with readers across the world. BioVox is an independent publisher, providing its community with quality content and first-row access to interesting breakthroughs and trends in biotech, medtech, agtech, pharma, and more. We shine a spotlight on the latest news and innovations from both our partners and community.

All posts

Subscribe to the BioVox newsletter